Dr. Yunik Chang is Director
Ophthalmic Product Development and Intellectual Property
Dow Pharmaceutical Sciences
Add this Podcast feed to your media player
For more than 10 years, Dow has been intimately involved in ophthalmic formulation development for various ocular diseases such as cataract, ocular hyphema, dry-eye, age-related macular degeneration, glaucoma, etc. This podcast will attempt to share such ophthalmic formulation technology with the scientists and formulators who are interested in developing eye-care products.